These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 37508254)
1. Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Batoni G; Catelli E; Kaya E; Pompilio A; Bianchi M; Ghelardi E; Di Bonaventura G; Esin S; Maisetta G Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508254 [TBL] [Abstract][Full Text] [Related]
2. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung. Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026 [TBL] [Abstract][Full Text] [Related]
3. Anti-Persisters Activity of Bianchi M; Esin S; Kaya E; Batoni G; Maisetta G Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000222 [TBL] [Abstract][Full Text] [Related]
4. The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum. Maisetta G; Grassi L; Esin S; Serra I; Scorciapino MA; Rinaldi AC; Batoni G Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926942 [No Abstract] [Full Text] [Related]
5. Cell-free supernatants from Lactobacillus strains exert antibacterial, antibiofilm, and antivirulence activity against Pseudomonas aeruginosa from cystic fibrosis patients. Pompilio A; Kaya E; Lupetti V; Catelli E; Bianchi M; Maisetta G; Esin S; Di Bonaventura G; Batoni G Microbes Infect; 2024; 26(4):105301. PubMed ID: 38237656 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967 [TBL] [Abstract][Full Text] [Related]
7. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation. Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004 [TBL] [Abstract][Full Text] [Related]
8. Effect of Shear Stress on Pseudomonas aeruginosa Isolated from the Cystic Fibrosis Lung. Dingemans J; Monsieurs P; Yu SH; Crabbé A; Förstner KU; Malfroot A; Cornelis P; Van Houdt R mBio; 2016 Aug; 7(4):. PubMed ID: 27486191 [TBL] [Abstract][Full Text] [Related]
9. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System. Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523 [TBL] [Abstract][Full Text] [Related]
10. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules. Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483 [TBL] [Abstract][Full Text] [Related]
11. Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients. Fricks-Lima J; Hendrickson CM; Allgaier M; Zhuo H; Wiener-Kronish JP; Lynch SV; Yang K Int J Antimicrob Agents; 2011 Apr; 37(4):309-15. PubMed ID: 21382698 [TBL] [Abstract][Full Text] [Related]
12. Competition in Biofilms between Cystic Fibrosis Isolates of Oluyombo O; Penfold CN; Diggle SP mBio; 2019 Jan; 10(1):. PubMed ID: 30696740 [No Abstract] [Full Text] [Related]
14. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells. Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung. Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970 [TBL] [Abstract][Full Text] [Related]
16. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873 [TBL] [Abstract][Full Text] [Related]
17. Effect of pH on the antimicrobial susceptibility of planktonic and biofilm-grown clinical Pseudomonas aeruginosa isolates. Moriarty TF; Elborn JS; Tunney MM Br J Biomed Sci; 2007; 64(3):101-4. PubMed ID: 17910277 [TBL] [Abstract][Full Text] [Related]